Journal rankings · indicator year 2025
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2025
Neuroscience journal rankings 2025
355 ranked journals · Field in Life Sciences
Neuroscience has 355 ranked journals in 2025. The median journal has an OJR of 0.86, below the world average of 1.00, down 0.03 on 2024; Q1 starts at OJR 1.21. The two highest-scoring journals with stable ranks are Nature Human Behaviour and Nature Neuroscience: each is likely ranked within the top 4.
Ranks and citation indicators: 2025. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2022–2024, the window the 2025 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Neuroscience (8)
Up to Life Sciences355 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. The small range under it is the likely rank range: in 95% of 1,000 resamples of the journal’s papers, it ranked inside that range. Journals whose ranges overlap are not clearly different. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2024. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2022–2024, the window the 2025 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2022–2024 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2016 to 2025. A label compares the 2022→2025 change with the median change of the journal’s field or domain. Rising needs a relative change of +10% or more that is at least 2 standard errors above zero; Falling needs -9.1% or less (rounded), at least 2 standard errors below zero. Sorting uses that relative change. | Compare |
|---|---|---|---|---|---|---|---|
Rank 1; likely between #1 and #2 of 355Nature Human BehaviourNature Portfolio · United Kingdom | 5.22Q1 | 12.54 0.80 up from 2024 | 786 | 46% | $12,690 | Falling vs field, 2022–25 | |
Rank 2; likely between #1 and #2 of 355Nature NeuroscienceNature Portfolio · United States | 4.95Q1 | 15.28 1.12 down from 2024 | 758 | 57% | $12,690 | Falling vs field, 2022–25 | |
Rank 3; likely between #3 and #6 of 355NeuronCell Press · United States | 3.80Q1 | 12.76 0.72 up from 2024 | 1,056 | 63% | $10,400 | Rising vs field, 2022–25 | |
Rank 4; likely between #3 and #8 of 355Current Directions in Psychological ScienceSAGE Publishing · United Kingdom | 3.51Q1 | 5.96 1.61 down from 2024 | 185 | 70% | $3,900 | ||
Rank 5; likely between #3 and #7 of 355Journal of NeuroinflammationOABioMed Central · United Kingdom | 3.50Q1 | 12.03 0.92 up from 2024 | 937 | 100% | $4,090 | Rising vs field, 2022–25 | |
Rank 6; likely between #3 and #12 of 355Annual Review of PsychologyAnnual Reviews · United States | 3.47Q1 | 19.41 7.55 down from 2024 | 82 | 93% | — | ||
Rank 7; likely between #5 and #9 of 355Molecular PsychiatrySpringer Nature · United Kingdom | 3.09Q1 | 10.40 0.45 down from 2024 | 1,402 | 70% | $5,490 | ||
Rank 8; likely between #5 and #19 of 355Communications PsychologyOASpringer Science+Business Media | 2.78Q1 | 5.72 2.06 up from 2024 | 173 | 100% | $2,090 | ||
Rank 9; likely between #7 and #17 of 355Nature reviews. NeuroscienceNature Portfolio · United Kingdom | 2.66Q1 | 13.48 0.05 up from 2024 | 328 | 17% | — | ||
Rank 10; likely between #4 and #43 of 355Brain InformaticsOASpringer Science+Business Media · Germany | 2.65Q1 | 12.71 5.68 up from 2024 | 96 | 100% | $1,090 | ||
Rank 11; likely between #7 and #25 of 355Psychological ReviewAmerican Psychological Association · United States | 2.54Q1 | 5.40 1.80 down from 2024 | 183 | 57% | — | ||
Rank 12; likely between #9 and #21 of 355Psychological ScienceSAGE Publishing · United States | 2.48Q1 | 4.87 0.75 down from 2024 | 330 | 71% | $3,900 | Falling vs field, 2022–25 | |
Rank 13; likely between #10 and #19 of 355Translational PsychiatryOASpringer Nature · United States | 2.41Q1 | 8.10 0.70 up from 2024 | 1,388 | 100% | $5,290 | Rising vs field, 2022–25 | |
Rank 14; likely between #7 and #37 of 355Frontiers in NeuroendocrinologyElsevier BV · United States | 2.40Q1 | 7.65 0.14 down from 2024 | 114 | 60% | $4,800 | ||
Rank 15; likely between #10 and #28 of 355Journal of Pineal ResearchWiley · Denmark | 2.32Q1 | 7.85 0.90 up from 2024 | 187 | 53% | $5,000 | ||
Rank 16; likely between #8 and #45 of 355ACM Transactions on Accessible ComputingAssociation for Computing Machinery · United States | 2.30Q1 | 4.50 0.97 down from 2024 | 80 | 75% | — | ||
Rank 17; likely between #9 and #41 of 355Nature Reviews PsychologyNature Portfolio · United Kingdom | 2.23Q1 | 8.78 2.09 down from 2024 | 382 | 14% | — | ||
Rank 18; likely between #14 and #33 of 355IEEE Transactions on Neural Systems and Rehabilitation EngineeringOAInstitute of Electrical and Electronics Engineers · United States | 2.15Q1 | 7.60 0.77 up from 2024 | 1,197 | 100% | $2,075 | Rising vs field, 2022–25 | |
Rank 19; likely between #9 and #51 of 355Neuroscience of ConsciousnessOAUniversity of Oxford · United Kingdom | 2.13Q1 | 5.42 1.21 down from 2024 | 83 | 100% | $2,544 | ||
Rank 20; likely between #17 and #32 of 355Neuroscience & Biobehavioral ReviewsElsevier BV · United States | 2.11Q1 | 8.93 0.20 down from 2024 | 1,172 | 66% | $4,860 | Rising vs field, 2022–25 | |
Rank 21; likely between #11 and #43 of 355Wiley Interdisciplinary Reviews Cognitive ScienceWiley · United States | 2.11Q1 | 4.25 0.79 down from 2024 | 89 | 50% | $4,150 | ||
Rank 22; likely between #13 and #46 of 355npj Science of LearningOANature Portfolio · United Kingdom | 2.09Q1 | 5.14 1.24 up from 2024 | 168 | 100% | $2,690 | ||
Rank 23; likely between #19 and #31 of 355Biomedical Signal Processing and ControlElsevier BV · United Kingdom | 2.08Q1 | 7.56 0.54 up from 2024 | 3,497 | 17% | $2,590 | Rising vs field, 2022–25 | |
Rank 24; likely between #14 and #42 of 355Molecular AutismOABioMed Central · United Kingdom | 2.08Q1 | 6.28 0.15 down from 2024 | 148 | 100% | $3,990 | ||
Rank 25; likely between #16 and #40 of 355AutismSAGE Publishing · United Kingdom | 2.06Q1 | 5.81 0.63 down from 2024 | 603 | 74% | $3,900 | Rising vs field, 2022–25 | |
Rank 26; likely between #16 and #39 of 355Behavior Research MethodsSpringer Science+Business Media · United States | 2.05Q1 | 5.53 0.78 up from 2024 | 779 | 71% | $3,990 | ||
Rank 27; likely between #15 and #45 of 355Fluids and Barriers of the CNSOABioMed Central · United Kingdom | 2.02Q1 | 7.37 0.51 up from 2024 | 297 | 100% | $3,390 | ||
Rank 28; likely between #17 and #41 of 355NeuropsychopharmacologySpringer Nature · United States | 2.02Q1 | 6.21 0.47 down from 2024 | 707 | 87% | $5,290 | ||
Rank 29; likely between #16 and #44 of 355Developmental Cognitive NeuroscienceOAElsevier BV · Netherlands | 2.01Q1 | 4.91 0.91 down from 2024 | 390 | 100% | $3,650 | ||
Rank 30; likely between #12 and #52 of 355Annual Review of NeuroscienceAnnual Reviews · United States | 2.01Q1 | 16.79 0.07 up from 2024 | 64 | 96% | — | ||
Rank 31; likely between #14 and #50 of 355Annals of the New York Academy of SciencesWiley · United States | 1.96Q1 | 4.68 1.17 down from 2024 | 474 | 65% | $5,080 | ||
Rank 32; likely between #16 and #49 of 355Health Information Science and SystemsSpringer Nature · United Kingdom | 1.95Q1 | 5.97 1.10 up from 2024 | 155 | 93% | $2,590 | ||
Rank 33; likely between #15 and #51 of 355Autism in AdulthoodMary Ann Liebert, Inc. · United States | 1.94Q1 | 4.66 2.86 down from 2024 | 215 | 53% | — | ||
Rank 34; likely between #16 and #50 of 355Progress in NeurobiologyElsevier BV · United Kingdom | 1.92Q1 | 4.69 2.16 down from 2024 | 246 | 66% | $5,190 | ||
Rank 35; likely between #27 and #45 of 355Brain Behavior and ImmunityElsevier BV · United States | 1.88Q1 | 7.05 0.21 up from 2024 | 1,049 | 48% | $5,680 | Falling vs field, 2022–25 | |
Rank 36; likely between #23 and #48 of 355Biological PsychiatryElsevier BV · United States | 1.88Q1 | 5.31 0.49 up from 2024 | 931 | 20% | $5,489 | ||
Rank 37; likely between #30 and #45 of 355NeuroImageOAElsevier BV · United States | 1.85Q1 | 5.60 0.05 down from 2024 | 1,825 | 100% | $3,540 | ||
Rank 38; likely between #9 and #82 of 355Autism ResearchWiley · United States | 1.84Q1 | 3.89 2.19 down from 2024 | 576 | 71% | $4,740 | ||
Rank 39; likely between #10 and #92 of 355Trends in Neuroscience and EducationElsevier BV · Netherlands | 1.83Q1 | 4.73 0.33 up from 2024 | 63 | 69% | $3,880 | ||
Rank 40; likely between #26 and #51 of 355Trends in Cognitive SciencesElsevier BV · United Kingdom | 1.82Q1 | 9.56 0.24 down from 2024 | 474 | 51% | $7,030 | ||
Rank 41; likely between #9 and #107 of 355Bioelectronic MedicineOABioMed Central · United Kingdom | 1.80Q1 | 8.14 2.39 up from 2024 | 77 | 100% | $2,590 | ||
Rank 42; likely between #27 and #51 of 355Journal of Experimental Psychology GeneralAmerican Psychological Association | 1.79Q1 | 3.79 0.52 down from 2024 | 529 | 45% | — | ||
Rank 43; likely between #35 and #49 of 355Current BiologyElsevier BV · United Kingdom | 1.76Q1 | 5.07 0.23 up from 2024 | 2,733 | 65% | $7,030 | ||
Rank 44; likely between #12 and #100 of 355Policy Insights from the Behavioral and Brain SciencesSAGE Publishing · United States | 1.75Q1 | 4.36 1.49 up from 2024 | 94 | 32% | $3,400 | ||
Rank 45; likely between #32 and #54 of 355Trends in NeurosciencesElsevier BV · United Kingdom | 1.74Q1 | 9.30 1.21 down from 2024 | 368 | 54% | $7,030 | Rising vs field, 2022–25 | |
Rank 46; likely between #17 and #97 of 355Journal of Memory and LanguageElsevier BV · United States | 1.68Q1 | 4.02 0.81 up from 2024 | 149 | 72% | $4,670 | ||
Rank 47; likely between #26 and #80 of 355Journal of Neuroimmune PharmacologySpringer Science+Business Media · United States | 1.66Q1 | 6.24 2.28 up from 2024 | 116 | 42% | $4,790 | ||
Rank 48; likely between #38 and #59 of 355GliaWiley · United States | 1.64Q1 | 5.74 0.08 down from 2024 | 429 | 70% | $5,450 | ||
Rank 49; likely between #32 and #81 of 355British Journal of PsychologyWiley · United Kingdom | 1.60Q1 | 3.67 0.05 down from 2024 | 179 | 72% | $3,800 | ||
Rank 50; likely between #29 and #93 of 355Cognitive PsychologyElsevier BV · United States | 1.58Q1 | 2.87 1.02 down from 2024 | 81 | 61% | $3,570 |
30 Neuroscience journals are labelled rising: their OJR moved up between 2022 and 2025 clearly faster than the median journal of their field or domain.
A journal is rising when its OJR grew from 2022 to 2025 faster than the median journal of its field (or domain, when the field is small), by two tests: the relative change is +10% or more, and it is at least 2 standard errors above zero. So the range of the change at 2 standard errors stays above zero, though not necessarily above +10%.
The bar is that range on a ratio scale; the shaded band, -9.1% to +10%, holds changes too small for a label. The list is ordered by the low end of the range, so the surest rises come first.
Full rising list for Neuroscience
- 1The Journal of EthicsCognitive Neuroscience+238% vs groupOJR 0.40 → 1.21range +100% to +471%
- 2Advances in Psychological ScienceOACognitive Neuroscience+113% vs groupOJR 0.26 → 0.50range +62% to +180%
- 3Advances in Neurodevelopmental DisordersCognitive Neuroscience+91% vs groupOJR 0.52 → 0.89range +36% to +169%
- 4Journal of Consciousness StudiesCognitive Neuroscience+128% vs groupOJR 0.37 → 0.75range +28% to +308%
- 5Neuroscience BulletinCognitive Neuroscience+53% vs groupOJR 1.01 → 1.38range +21% to +93%
- 6IEEE Transactions on Neural Systems and Rehabilitation EngineeringOACognitive Neuroscience+39% vs groupOJR 1.75 → 2.15range +20% to +60%
- 7Cognitive ScienceCognitive Neuroscience+52% vs groupOJR 0.94 → 1.27range +19% to +93%
- 8Journal of NeuroinflammationOANeurology+32% vs groupOJR 2.99 → 3.50range +17% to +48%
- 9Brain Research BulletinOACognitive Neuroscience+31% vs groupOJR 1.17 → 1.36range +15% to +49%
- 10Biomedical Signal Processing and ControlCognitive Neuroscience+25% vs groupOJR 1.87 → 2.08range +15% to +36%
- 11VisionOACognitive Neuroscience+57% vs groupOJR 0.65 → 0.90range +13% to +117%
- 12NeuroreportCognitive Neuroscience+29% vs groupOJR 0.53 → 0.60range +9.8% to +51%
- 13Cognitive NeurodynamicsCognitive Neuroscience+38% vs groupOJR 1.16 → 1.42range +8.7% to +76%
- 14Neuroscience and Behavioral PhysiologyCognitive Neuroscience+38% vs groupOJR 0.15 → 0.18range +6.7% to +78%
- 15Brain stimulationOANeurology+22% vs groupOJR 1.20 → 1.30range +6.2% to +40%
- 16Journal of Communication DisordersCognitive Neuroscience+35% vs groupOJR 0.92 → 1.10range +5.9% to +73%
- 17NeuronCognitive Neuroscience+21% vs groupOJR 3.52 → 3.80range +5.7% to +39%
- 18Hearing ResearchCognitive Neuroscience+26% vs groupOJR 0.91 → 1.02range +4.7% to +52%
- 19Biological PsychologyCognitive Neuroscience+26% vs groupOJR 1.08 → 1.20range +4.4% to +52%
- 20Current Opinion in NeurobiologyCognitive Neuroscience+24% vs groupOJR 0.62 → 0.68range +4.4% to +48%
No-label zone, -9.1% to +10%Group median changeBar scale -84% to +523% (ratio scale)
25 Neuroscience journals are labelled falling: their OJR moved between 2022 and 2025 clearly behind the median journal of their field or domain.
A journal is falling when its OJR changed from 2022 to 2025 by less than the median journal of its field (or domain, when the field is small), by two tests: the relative change is -9.1% or less (rounded), and it is at least 2 standard errors below zero. So the range of the change at 2 standard errors stays below zero, though not necessarily below -9.1%.
The bar is that range on a ratio scale; the shaded band, -9.1% to +10%, holds changes too small for a label. The list is ordered by the high end of the range, so the surest falls come first.
- 1Journal of VisionOACognitive Neuroscience-59% vs groupOJR 0.45 → 0.16range -66% to -50%
- 2Brain Behavior and ImmunityBiological Psychiatry-37% vs groupOJR 3.34 → 1.88range -49% to -21%
- 3Visual CognitionCognitive Neuroscience-45% vs groupOJR 0.83 → 0.40range -64% to -18%
- 4Psychological ScienceCognitive Neuroscience-34% vs groupOJR 4.24 → 2.48range -49% to -16%
- 5Brain Behavior & Immunity - HealthOABiological Psychiatry-34% vs groupOJR 1.66 → 0.97range -49% to -16%
- 6Memory & CognitionCognitive Neuroscience-29% vs groupOJR 1.09 → 0.69range -42% to -12%
- 7Journal of Experimental Psychology Learning Memory and CognitionCognitive Neuroscience-29% vs groupOJR 1.27 → 0.80range -44% to -9.7%
- 8Psychonomic Bulletin & ReviewCognitive Neuroscience-28% vs groupOJR 1.90 → 1.21range -43% to -9.5%
- 9Journal of Autism and Developmental DisordersCognitive Neuroscience-18% vs groupOJR 1.49 → 1.08range -27% to -8.5%
- 10CognitionCognitive Neuroscience-19% vs groupOJR 1.91 → 1.37range -29% to -7.7%
- 11Nature NeuroscienceCognitive Neuroscience-20% vs groupOJR 7.00 → 4.95range -31% to -7.6%
- 12Frontiers in NeuroscienceOACognitive Neuroscience-12% vs groupOJR 1.62 → 1.27range -17% to -6.8%
- 13Nature Human BehaviourCognitive Neuroscience-30% vs groupOJR 8.36 → 5.22range -48% to -5.9%
- 14Chemical SensesSensory Systems-36% vs groupOJR 1.18 → 0.67range -57% to -5.4%
- 15Journal of CognitionOACognitive Neuroscience-47% vs groupOJR 2.17 → 1.03range -70% to -4.8%
- 16Journal of NeuroscienceCognitive Neuroscience-12% vs groupOJR 1.64 → 1.29range -18% to -4.8%
- 17Frontiers in Cellular NeuroscienceOACellular and Molecular Neuroscience-14% vs groupOJR 1.77 → 1.35range -23% to -4.6%
- 18International Journal of AudiologyCognitive Neuroscience-23% vs groupOJR 0.87 → 0.59range -39% to -4.3%
- 19Pharmacology Biochemistry and BehaviorCellular and Molecular Neuroscience-21% vs groupOJR 1.12 → 0.79range -35% to -3.6%
- 20American Journal of Clinical HypnosisCognitive Neuroscience-46% vs groupOJR 0.31 → 0.15range -70% to -3.5%
No-label zone, -9.1% to +10%Group median changeBar scale -72% to +257% (ratio scale)
The endpoints below each rank show its likely range. How rank ranges are calculated
Citations made in 2025. Corpus-wide, 84.3% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
42 additional Neuroscience journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2022–2024, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2025. Publication window: 2022–2024. How these summaries are calculated
- Ranked journals
- 355
- Window papers (baseline)
- 218,119 +3.5% from indicator year 2022
- Median OJR
- 0.86 -6.2% from indicator year 2022
- Rising journals (2025)
- 30Comparison-group list (30)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2022–2024 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 196 | 201 | 210 | 220 | 223 | 230 | 231 | 238 | 242 | 248 | 266 | 276 | 290 | 292 | 295 | 306 | 314 | 319 | 321 | 328 | 332 | 344 | 352 | 356 | 360 | 355 | |
| Window papers (baseline) | 92,779 | 97,762 | 100,667 | 104,810 | 108,324 | 115,003 | 120,244 | 126,308 | 131,531 | 143,118 | 150,842 | 164,012 | 167,583 | 173,307 | 175,900 | 181,549 | 185,572 | 184,543 | 184,806 | 187,130 | 193,371 | 201,253 | 210,793 | 215,142 | 216,969 | 218,119 | |
| Median OJR | 0.79 | 0.84 | 0.889 | 0.91 | 0.924 | 0.998 | 1.04 | 0.9996 | 1.024 | 1.094 | 1.146 | 1.136 | 1.16 | 1.150 | 1.141 | 1.086 | 1.083 | 1.076 | 1.022 | 1.06 | 1.01 | 0.93 | 0.918 | 0.90 | 0.890 | 0.86 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 3.2% | 293 journals |
| Retracted papers per 1,000 | Pooled rate: 0.951 per 1,000 | 257 journals |
| Output growth | Median: -9.4% | 327 journals |
| Open access share | Median: 68.0% | 355 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,555 | 226 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 27.0% | 344 journals |
| Review share | Median: 1.4% | 355 journals |
| Articles-only OJR | Median: 0.86 | 349 journals |
| Uncited share | Median: 27.2% | 355 journals |
| Citation concentration | Median: 43.1% | 355 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.